Health Longevity Secrets

The Future of Aging with Aubrey de Grey

12 snips
Apr 15, 2025
Aubrey de Grey, a leading biomedical gerontologist and founder of the LEV Foundation, discusses his pioneering work aimed at reversing aging. He explains why aging may be more easily reversible than previously thought. The conversation dives into major players in longevity research like HEvolution and Calico, revealing insights about their differing approaches. Regulatory innovations, such as Montana's Right to Try legislation, are highlighted as crucial for accelerating advancements. De Grey also shares details about a groundbreaking study with middle-aged mice targeting significant lifespan extension.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

Saudi Investment in Longevity

  • The Saudi royal family's plan to invest $1 billion annually for 20 years in longevity research is unprecedented.
  • Progress has been slow but foundational groundwork and strong leadership promise major future impact.
INSIGHT

Longevity Company Differentiation

  • Calico by Google has struggled due to poor pipeline and lack of translation to products.
  • Retro Biosciences, led by Joe Betts-Lacroix and funded by Sam Altman, shows the most promise due to focused leadership and strategy.
INSIGHT

Prospera's Regulatory Innovation

  • Prospera in Honduras is a special economic zone designed to expedite biomedical innovation with flexible regulations.
  • It could become the global hub for medical tourism and accelerate drug development by bypassing slow traditional approval processes.
Get the Snipd Podcast app to discover more snips from this episode
Get the app